Athens, GA – According to filings with the U.S. Securities and Exchange Commission, Blue Lake Biotechnology is raising $8,750,000.00 in new funding. Sources indicate as part of senior management President, Biao He played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Blue Lake Biotechnology

We are a vaccine company focusing on developing human vaccines using novel technology.

To learn more about Blue Lake Biotechnology, visit http://www.bluelakebiotechnology.com/

Contact:
Biao He, President
706-201-7798

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved